SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-159238
Filing Date
2021-05-12
Accepted
2021-05-12 17:02:20
Documents
12
Period of Report
2021-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d31397d8k.htm 8-K 17765
2 EX-99.1 d31397dex991.htm EX-99.1 56410
3 EX-99.2 d31397dex992.htm EX-99.2 59351
4 GRAPHIC g31397g0512204330773.jpg GRAPHIC 16492
5 GRAPHIC g31397g0512204331054.jpg GRAPHIC 19877
6 GRAPHIC g31397g0512204331241.jpg GRAPHIC 14823
7 GRAPHIC g31397g0512204331397.jpg GRAPHIC 12224
8 GRAPHIC g31397g0512204331569.jpg GRAPHIC 11139
9 GRAPHIC g31397g0512204331803.jpg GRAPHIC 20617
10 GRAPHIC g31397g0512204332006.jpg GRAPHIC 26195
11 GRAPHIC g31397g0512204332193.jpg GRAPHIC 13392
12 GRAPHIC g31397g0512204731096.jpg GRAPHIC 2278
  Complete submission text file 0001193125-21-159238.txt   325038
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 21915966
SIC: 2834 Pharmaceutical Preparations